Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of this industry, showing challenges and opportunities for startups developing solutions in this sector.

Support @moniology on @patreon. #OnPatreon:
Please pledge your support of $10 or $25 today!
https://goo.gl/rYtvGg
$KTOV $MBVX $MNKD $MBOT $MBRX $MYOS $NURO $NWBO $NVAX $NYMX
Follow me @ Stocktwits/Moniology and Twitter.com/Moniology
**Disclaimer** This video is for educational and information purposes only. Please do your own due diligence before determining whether to buy or sell any security.

published:04 Feb 2018

views:161

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Healthcare and biotech stocks should rally as they are undervalued relative to the S and P500.

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Galactic quadrant (Star Trek)

In the television series Star Trek and its spin-offs, a galactic quadrant refers to an area of the Milky Way Galaxy. In the original Star Trek, it referred to an area interchangeable with a sector. However, in the various spin-off series and movies beginning with Star Trek: The Next Generation, it refers to a system of four galactic quadrants, designated by the Greek letters Alpha, Beta, Gamma, and Delta.

Original usage

The original usage of quadrant occurs in episodes such as "The Deadly Years" and "The Squire of Gothos", where numbered quadrants (448 and 904) are given. In other episodes it appears to refer to an entire quarter of the galaxy. The season 3 Star Trek: The Next Generation Writers' Technical Manual asserts that there are four quadrants in each sector (which seem to vary in size).

Four quadrants

The exact quadrant borders are not clearly established in the series canon. Episodes often contradict each other. Art staff explanations also contradict each other.
The 1988 Star Trek: The Next Generation episode "The Price" introduced the concept of four quadrants of the galaxy, named the Alpha, Beta, Gamma and Delta quadrants.

Notes

External links

List of Star Trek regions of space

Several films and episodes of the science fiction franchise Star Trek are set in distinct regions of space. Some of these fictional locations exhibit anomalous physical properties; others are defined as sensitive buffer zones under various fictional political accords.

This list describes some of the more significant settings for Star Trek films or story arcs over multiple television episodes.

Badlands

Located in Star Trek's Alpha Quadrant, the Badlands are characterized by constant plasma storms and funnel clouds. The Maquis use it in several episodes as a meeting or hiding place because of its treacherous navigation. It is also known to have a few planets hidden within the clouds and nebulae.

Business telephone system

A business telephone system is a multiline telephone system typically used in business environments, encompassing systems ranging from small key telephone systems to large-scale private branch exchanges.

A business telephone system differs from an installation of several telephones with multiple central office (CO) lines in that the CO lines used are directly controllable in key telephone systems from multiple telephone stations, and that such a system often provides additional features related to call handling. Business telephone systems are often broadly classified into key telephone systems, and private branch exchanges, but many hybrid systems exist.

A key telephone system was originally distinguished from a private branch exchange (PBX) in that it did not require an operator or attendant at the switchboard to establish connections between the central office trunks and stations, or between stations. Technologically, private branch exchanges share lineage with central office telephone systems, and in larger or more complex systems, may rival a central office system in capacity and features. With a key telephone system, a station user could control the connections directly using line buttons, which indicated the status of lines with built-in lamps.

Follow Me (Amanda Lear song)

Song information

"Follow Me" was released as the first single from Amanda's second album, Sweet Revenge, in the spring of 1978. The B-side of the single was "Mother, Look What They've Done to Me" in most countries. The only exception to this in Europe was Spain, with "Run Baby Run", that would later become the second A-side release off the album, and where the single bore the subtitle "Sigueme". In Canada, the B-side was "Enigma (Give a Bit of Mmh to Me)", later a separate single from the album.

Amanda Lear wrote the song lyrics herself, as she did on every Sweet Revenge track, and the music was composed by Anthony Monn, her long-time producer and collaborator. Musically, "Follow Me" showcased mainstream disco sound, popular in the second half of the 1970s. However, it contained symphonic elements and revealed inspiration from the innovatory work of German band Kraftwerk. Lyrically, the song tells about seduction. It was the first of five Sweet Revenge tracks, that made a compact whole on the album, a conceptual suite telling a story about a girl being tempted by a Devil. An alternative version of "Follow Me" tops the suite, billed as "Follow Me (Reprise)" and containing different lyrics. A 10-minute Wally MacDonald remix of the song was released in Canada, which was a blend of the original version and the reprise.

Follow Me (Atomic Kitten song)

"Follow Me" is a song by Atomic Kitten, released as the fourth single from their debut album, Right Now. The song was a departure from the pure pop of their first three singles, showcasing a more mellow, R&B-influenced pop sound. It was less successful than their previous top 10 hits, peaking at #20 on the UK Singles Chart. The single sold 41,628 copies in the United Kingdom.

Subsequently, "Follow Me" was the group's only single release to be left off their 2004 Greatest Hits album.

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

The future of the biotech industry

5:21

Framingham: Growing Biotech Sector

Framingham: Growing Biotech Sector

Framingham: Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

The Biotech Sector is still the #1 ranked Best Stocks Now App sector.

Biotech: Opportunities and Challenges in this sector

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of this industry, showing challenges and opportunities for startups developing solutions in this sector.

Biotech Sector Top Picks Part 5, Feb 4th, 2018

Support @moniology on @patreon. #OnPatreon:
Please pledge your support of $10 or $25 today!
https://goo.gl/rYtvGg
$KTOV $MBVX $MNKD $MBOT $MBRX $MYOS $NURO $NWBO $NVAX $NYMX
Follow me @ Stocktwits/Moniology and Twitter.com/Moniology
**Disclaimer** This video is for educational and information purposes only. Please do your own due diligence before determining whether to buy or sell any security.

2:57

📈Biotech Stocks as an Investment for 2018📈

📈Biotech Stocks as an Investment for 2018📈

📈Biotech Stocks as an Investment for 2018📈

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Healthcare and biotech stocks should rally as they are undervalued relative to the S and P500.

Framingham: A Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

2:20

Why join the Biotech sector?

Why join the Biotech sector?

Why join the Biotech sector?

JasonJohal is a Manager at CK Science who specialises in the biotechnology industry. In this video he speaks about how the biotechnology industry is out pacing all others and why this is a great field to get in to.
Watch our next video about the StemCell sector here:
http://youtu.be/GQW_v0xQ-tk
For more information contact Jason on 01438 723 500 or email jjohal@ckscience.co.uk

3:40

Biotech Sector Analysis - IBB

Biotech Sector Analysis - IBB

Biotech Sector Analysis - IBB

2:29

Cuba Combines Biotech Sector into Single Company to Increase Technology Exports

Cuba Combines Biotech Sector into Single Company to Increase Technology Exports

Cuba Combines Biotech Sector into Single Company to Increase Technology Exports

Correspondent Michael Voss reports on Cuba's efforts to increase exports in the technology sector by creating a single biotech conglomerate and relieving the country from dependence on material exports.

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

The future of the biotech industry

published: 14 Mar 2017

Framingham: Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

published: 04 Jun 2018

The Biotech Sector is still the #1 ranked Best Stocks Now App sector.

Biotech: Opportunities and Challenges in this sector

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of this industry, showing challenges and opportunities for startups developing solutions in this sector.

Biotech Sector Top Picks Part 5, Feb 4th, 2018

Support @moniology on @patreon. #OnPatreon:
Please pledge your support of $10 or $25 today!
https://goo.gl/rYtvGg
$KTOV $MBVX $MNKD $MBOT $MBRX $MYOS $NURO $NWBO $NVAX $NYMX
Follow me @ Stocktwits/Moniology and Twitter.com/Moniology
**Disclaimer** This video is for educational and information purposes only. Please do your own due diligence before determining whether to buy or sell any security.

published: 04 Feb 2018

📈Biotech Stocks as an Investment for 2018📈

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Healthcare and biotech stocks should rally as they are undervalued relative to the S and P500.

Framingham: A Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

published: 27 Mar 2018

Why join the Biotech sector?

JasonJohal is a Manager at CK Science who specialises in the biotechnology industry. In this video he speaks about how the biotechnology industry is out pacing all others and why this is a great field to get in to.
Watch our next video about the StemCell sector here:
http://youtu.be/GQW_v0xQ-tk
For more information contact Jason on 01438 723 500 or email jjohal@ckscience.co.uk

published: 20 May 2014

Biotech Sector Analysis - IBB

published: 27 Jul 2015

Cuba Combines Biotech Sector into Single Company to Increase Technology Exports

Correspondent Michael Voss reports on Cuba's efforts to increase exports in the technology sector by creating a single biotech conglomerate and relieving the country from dependence on material exports.

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small ...

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

Framingham: Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that indus...

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Biotech: Opportunities and Challenges in this sector

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of th...

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of this industry, showing challenges and opportunities for startups developing solutions in this sector.

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of this industry, showing challenges and opportunities for startups developing solutions in this sector.

📈Biotech Stocks as an Investment for 2018📈

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Hea...

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Healthcare and biotech stocks should rally as they are undervalued relative to the S and P500.

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Healthcare and biotech stocks should rally as they are undervalued relative to the S and P500.

Framingham: A Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that indus...

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Why join the Biotech sector?

JasonJohal is a Manager at CK Science who specialises in the biotechnology industry. In this video he speaks about how the biotechnology industry is out pacing...

JasonJohal is a Manager at CK Science who specialises in the biotechnology industry. In this video he speaks about how the biotechnology industry is out pacing all others and why this is a great field to get in to.
Watch our next video about the StemCell sector here:
http://youtu.be/GQW_v0xQ-tk
For more information contact Jason on 01438 723 500 or email jjohal@ckscience.co.uk

JasonJohal is a Manager at CK Science who specialises in the biotechnology industry. In this video he speaks about how the biotechnology industry is out pacing all others and why this is a great field to get in to.
Watch our next video about the StemCell sector here:
http://youtu.be/GQW_v0xQ-tk
For more information contact Jason on 01438 723 500 or email jjohal@ckscience.co.uk

Cuba Combines Biotech Sector into Single Company to Increase Technology Exports

Correspondent Michael Voss reports on Cuba's efforts to increase exports in the technology sector by creating a single biotech conglomerate and relieving the co...

Correspondent Michael Voss reports on Cuba's efforts to increase exports in the technology sector by creating a single biotech conglomerate and relieving the country from dependence on material exports.

Correspondent Michael Voss reports on Cuba's efforts to increase exports in the technology sector by creating a single biotech conglomerate and relieving the country from dependence on material exports.

Owning a takeover target is one of the quickest ways to profits in the biotech sector. Biotech investing expert Bret Jensen will show you how to identify small and mid-size biotech companies with promising technologies that make them potential targets for acquisition from larger firms like Gilead, Amgen, Celgene and others. Bret will share with you the details of his process for screening potential takeover targets with a laser like focus. He'll also show you how to use his 4 criteria for any potential biotech takeover stock.

Framingham: Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Biotech: Opportunities and Challenges in this sector

Along with a group of experts from Canada and Latin America, LatAm Startups is putting together a discussion around the Biotech sector, present and future of this industry, showing challenges and opportunities for startups developing solutions in this sector.

📈Biotech Stocks as an Investment for 2018📈

The Biotech Sector is undervalued and the big money wants higher. The entire sector has room to appreciate significantly compared to the rest of the market. Healthcare and biotech stocks should rally as they are undervalued relative to the S and P500.

Framingham: A Growing Biotech Sector

Around the globe, Boston and Cambridge are viewed as centers of excellence for biotech and pharmaceutical research. But it might surprise you to know that industry giant Sanofi Genzyme has 1700 of its 5000 employees working in Framingham.

Why join the Biotech sector?

JasonJohal is a Manager at CK Science who specialises in the biotechnology industry. In this video he speaks about how the biotechnology industry is out pacing all others and why this is a great field to get in to.
Watch our next video about the StemCell sector here:
http://youtu.be/GQW_v0xQ-tk
For more information contact Jason on 01438 723 500 or email jjohal@ckscience.co.uk

Biotech Sector Analysis - IBB

Galactic quadrant (Star Trek)

In the television series Star Trek and its spin-offs, a galactic quadrant refers to an area of the Milky Way Galaxy. In the original Star Trek, it referred to an area interchangeable with a sector. However, in the various spin-off series and movies beginning with Star Trek: The Next Generation, it refers to a system of four galactic quadrants, designated by the Greek letters Alpha, Beta, Gamma, and Delta.

Original usage

The original usage of quadrant occurs in episodes such as "The Deadly Years" and "The Squire of Gothos", where numbered quadrants (448 and 904) are given. In other episodes it appears to refer to an entire quarter of the galaxy. The season 3 Star Trek: The Next Generation Writers' Technical Manual asserts that there are four quadrants in each sector (which seem to vary in size).

Four quadrants

The exact quadrant borders are not clearly established in the series canon. Episodes often contradict each other. Art staff explanations also contradict each other.
The 1988 Star Trek: The Next Generation episode "The Price" introduced the concept of four quadrants of the galaxy, named the Alpha, Beta, Gamma and Delta quadrants.

“We will provide our full support for development of the sector by forming public private partnership (PPP), bio-incubation centre, and biotech finishing schools. We will collaborate with various international organizations to provide cutting-edge technology in the biotechsector,” said Patra....

We will collaborate with various international organizations to provide cutting-edge technology in the biotechsector," the Minister said ... "Our new policy will take care of many matters and will support entry-level and later stage product development in the biotechsector in Odisha," he added....

“We will provide our full support for development of the sector by forming public private partnership (PPP), bio-incubation centre, and biotech finishing schools. We will collaborate with various international organizations to provide cutting-edge technology in the biotechsector,” said Patra....

We will collaborate with various international organizations to provide cutting-edge technology in the biotechsector," the Minister said ... "Our new policy will take care of many matters and will support entry-level and later stage product development in the biotechsector in Odisha," he added....

Despite this, the stock has been hammered so far in the fourth quarter, like most small cap biotechs during the recent bear market in this space ... With the recent pullback in the shares during the plunge across the biotechsector, we view Verastem's risk/reward profile as extremely favorable at these levels....

“We believe the strong investor response to this heavily oversubscribed offering speaks volumes about the enormous potential of Orchestra BioMed’s product pipeline as well as its innovative business model which applies proven value creation strategies from the biotechsector to the medtech arena,” said Adam Stern, CEO of SternAegis Ventures...Source....

It has been a brutal fourth quarter for the biotechsector. The sector entered an 'official' bear market towards the end of October, bounced some to begin November but after an eight percent loss during the Friday and Monday trading sessions in the SPDRBiotechETF (XBI) ... I have a full stake in Neos within a diversified biotech portfolio....

Digital healthcare investments are benefiting from the surfeit of cash that is lifting the biotechsector and, in fact, all industries in 2018 ... Digital Medicine & Medtech Showcase at Biotech Showcase™ is the ... Attendees also receive full access to the Biotech Showcase program....

You have to wonder what people in places like Appalachia or the RustBelt are thinking about Amazon's much-awaited HQ2 decision ... (Nashville got a consolation prize of a 5,000-job fulfillment center.) ... Virtually the entire tech sector is located in the liberal states of California and Washington. Biotech is largely a bi-coastal, blue-state phenomenon....

This is the fourth article of the Biotech Bio Series. Big pharma and biotechnology is one of the most exciting sectors in the world today, researching and developing drugs that allow all of us to live longer than ever before ... The most glaring fear is Abbvie’s (ABBV) upadacitinib As I described in “Biotech Bio Series #3....

Co-manager Henry He joined American Century in 2011 after serving as a senior equity research analyst and portfolio manager at BNP Paribas Investment Partners, where he covered the health care sector and managed the firm's global health care and biotech funds ... health care sector....

Money-losing drugmaker Cstone Pharmaceuticals has filed to make an initial public offering (IPO) in Hong Kong, becoming the latest such firm to take advantage of rules relaxed earlier this year that allowed firms from the hot biotechsector to make such listings....

Money-losing companies from the biotech and e-commerce sectors have filed for U.S ... Moderna’s IPO would become the latest from a new generation of money-losing biotech firms that have sprung up in China over the last few years, aiming to tap the nation’s growing demand for drugs that are biologically developed....